SPAS System

Company Overview

Snapshot

Founded in February 2019, SPAS System operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on the development and commercialization of a stent positioning assistance system (SPAS) for percutaneous coronary intervention (PCI) procedures. A significant milestone includes a 55-patient first-in-human multicenter clinical study conducted in Israel, which reported no device-related adverse events and high operator satisfaction.

Business overview

SPAS System develops and commercializes a stent positioning assistance system (SPAS) designed to enhance the safety and speed of percutaneous coronary intervention (PCI) procedures. Its core technology is a torque-like accessory that enables accurate, millimeter-precise stent positioning, aiming to minimize geographical misses and improve deployment control. The company serves the healthcare industry, specifically hospitals and surgical centers, operating within the Health Tech & Life Sciences sector, with a focus on Medical Devices and Medical Treatment & Therapeutics.

Company Intelligence Q&A

What is the primary product developed by SPAS System?

SPAS System develops the SPAS (Stent Positioning Assistance System), a torque-like accessory designed for accurate and precise stent positioning during percutaneous coronary intervention (PCI) procedures.

What problem does the SPAS system aim to solve in PCI procedures?

The SPAS system aims to minimize and potentially eliminate geographical misses during stent placement, enable confident performance by less experienced interventional cardiologists, and shorten procedural times for complex PCIs by allowing accurate, millimeter-precise stent positioning.

Has the SPAS system undergone clinical validation?

Yes, a 55-patient first-in-human multicenter clinical study was conducted in Israel, which reported no device-related adverse events. All five investigators stated that SPAS improved their ability to control stent deployment and achieve better accuracy in its positioning.

What is the regulatory classification of the SPAS device?

The SPAS device is classified as a Class 2a medical device.

Who is a founder of SPAS System?

Inna Martin is a founder and the COO of SPAS System.